Insider Transactions in Q2 2024 at Amylyx Pharmaceuticals, Inc. (AMLX)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 15
2024
|
Gina Mazzariello Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,455
-6.46%
|
$10,455
$1.88 P/Share
|
|
May 15
2024
|
Daphne Quimi |
BUY
Open market or private purchase
|
Direct |
2,250
+31.03%
|
$2,250
$1.89 P/Share
|
|
May 14
2024
|
Daphne Quimi |
BUY
Open market or private purchase
|
Direct |
2,750
+50.0%
|
$2,750
$1.88 P/Share
|
|
Apr 16
2024
|
Camille L Bedrosian Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
96,910
+38.43%
|
-
|
|
Apr 16
2024
|
Justin B. Klee Co-Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
179,850
+5.42%
|
-
|
|
Apr 16
2024
|
Gina Mazzariello Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
80,560
+33.22%
|
-
|
|
Apr 16
2024
|
Joshua B Cohen Co-Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
179,850
+5.32%
|
-
|
|
Apr 16
2024
|
James M Frates Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
91,180
+28.75%
|
-
|